Impact Biomedical Inc. Revenue 2022–2025
Impact Biomedical Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Impact Biomedical Inc. revenue for the quarter ending March 31, 2026 was 7000.
- Impact Biomedical Inc. revenue for the twelve months ending March 31, 2026 was 82000.
- Impact Biomedical Inc. annual revenue for 2025 was 32000, a 36.00% decrease from 2022.
- Impact Biomedical Inc. annual revenue for 2022 was 50000.
Impact Biomedical Inc. (IBO) — Frequently Asked Questions
Impact Biomedical Inc. (IBO) is a publicly traded US company. It has a market capitalization of $60M. In fiscal 2025 it reported revenue of $32,000 and net income of -$12M. Explore IBO's stock price, financial statements, earnings history, margins and key ratios below.
What is Impact Biomedical Inc.'s market cap?
Impact Biomedical Inc. (IBO) has a market capitalization of $60M.
What is the IBO stock price?
IBO trades at $0.57 (-1.39% on the day).
How much revenue does Impact Biomedical Inc. make?
Impact Biomedical Inc. reported revenue of $32,000 in fiscal 2025.
Is IBO profitable?
In fiscal 2025, Impact Biomedical Inc. reported net income of -$12M.